Literature DB >> 29542692

Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma.

Patrick A Ott, Zhuting Hu, Derin B Keskin, Sachet A Shukla, Jing Sun, David J Bozym, Wandi Zhang, Adrienne Luoma, Anita Giobbie-Hurder, Lauren Peter, Christina Chen, Oriol Olive, Todd A Carter, Shuqiang Li, David J Lieb, Thomas Eisenhaure, Evisa Gjini, Jonathan Stevens, William J Lane, Indu Javeri, Kaliappanadar Nellaiappan, Andres M Salazar, Heather Daley, Michael Seaman, Elizabeth I Buchbinder, Charles H Yoon, Maegan Harden, Niall Lennon, Stacey Gabriel, Scott J Rodig, Dan H Barouch, Jon C Aster, Gad Getz, Kai Wucherpfennig, Donna Neuberg, Jerome Ritz, Eric S Lander, Edward F Fritsch, Nir Hacohen, Catherine J Wu.   

Abstract

This corrects the article DOI: 10.1038/nature22991.

Entities:  

Year:  2018        PMID: 29542692      PMCID: PMC6064631          DOI: 10.1038/nature25145

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1 in total

1.  An immunogenic personal neoantigen vaccine for patients with melanoma.

Authors:  Patrick A Ott; Zhuting Hu; Derin B Keskin; Sachet A Shukla; Jing Sun; David J Bozym; Wandi Zhang; Adrienne Luoma; Anita Giobbie-Hurder; Lauren Peter; Christina Chen; Oriol Olive; Todd A Carter; Shuqiang Li; David J Lieb; Thomas Eisenhaure; Evisa Gjini; Jonathan Stevens; William J Lane; Indu Javeri; Kaliappanadar Nellaiappan; Andres M Salazar; Heather Daley; Michael Seaman; Elizabeth I Buchbinder; Charles H Yoon; Maegan Harden; Niall Lennon; Stacey Gabriel; Scott J Rodig; Dan H Barouch; Jon C Aster; Gad Getz; Kai Wucherpfennig; Donna Neuberg; Jerome Ritz; Eric S Lander; Edward F Fritsch; Nir Hacohen; Catherine J Wu
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

  1 in total
  9 in total

Review 1.  Acquired resistance to cancer immunotherapy.

Authors:  Arianna Draghi; Christopher Aled Chamberlain; Andrew Furness; Marco Donia
Journal:  Semin Immunopathol       Date:  2018-07-02       Impact factor: 9.623

Review 2.  Cancer research in the era of immunogenomics.

Authors:  Yochai Wolf; Yardena Samuels
Journal:  ESMO Open       Date:  2018-12-26

Review 3.  A Review in Research Progress Concerning m6A Methylation and Immunoregulation.

Authors:  Caiyan Zhang; Jinrong Fu; Yufeng Zhou
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

4.  Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer.

Authors:  Fangfang Xu; Tingwei Liu; Zhuonan Zhou; Chang Zou; Shaohua Xu
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

Review 5.  Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.

Authors:  Dong-Rui Wang; Xian-Lin Wu; Ying-Li Sun
Journal:  Signal Transduct Target Ther       Date:  2022-09-19

6.  Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses.

Authors:  Dorian A Stolk; Aram de Haas; Jana Vree; Sanne Duinkerken; Joyce Lübbers; Rieneke van de Ven; Martino Ambrosini; Hakan Kalay; Sven Bruijns; Hans J van der Vliet; Tanja D de Gruijl; Yvette van Kooyk
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

7.  Inactivation of DNA repair-prospects for boosting cancer immune surveillance.

Authors:  Anna Truini; Giovanni Germano; Alberto Bardelli
Journal:  Genome Med       Date:  2018-11-28       Impact factor: 11.117

8.  Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth.

Authors:  Manisit Das; Xuefei Zhou; Yun Liu; Anirban Das; Benjamin G Vincent; Jingjing Li; Rihe Liu; Leaf Huang
Journal:  Transl Oncol       Date:  2020-08-28       Impact factor: 4.243

Review 9.  Antitumor Peptide-Based Vaccine in the Limelight.

Authors:  Takumi Kumai; Hidekiyo Yamaki; Michihisa Kono; Ryusuke Hayashi; Risa Wakisaka; Hiroki Komatsuda
Journal:  Vaccines (Basel)       Date:  2022-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.